RecruitingNot ApplicableNCT07300540

Real-World Study of a Calcium Sodium Phosphosilicate Anti-Sensitivity Toothpaste for Dentin Hypersensitivity Relief

A Real-World Evidence Study Evaluating Oral Health Related Quality of Life With Use of a Calcium Sodium Phosphosilicate Anti-Sensitivity Dentifrice for Dentin Hypersensitivity Management

Sponsor

HALEON

Enrollment

500 participants

Start Date

Mar 4, 2026

Study Type

INTERVENTIONAL

Conditions

Dentin Sensitivity

Summary

The aim of this study is to evaluate the impact of a commercially available desensitizing dentifrice containing 5 percent (%) Calcium sodium phosphosilicate (CSPS) on oral health related quality of life (OHrQoL) in a DH (Dentin Hypersensitivity) population in a real-world setting.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

Participant who has provided consent indicating they have been informed of all pertinent aspects of the study.
All genders who, at the time of screening, are aged 18 to 65.
Participant who is able to independently complete all activities on their smart devices
Participant who has tooth sensitivity (self-reported symptoms).

Exclusion Criteria8

Participants whose tooth sensitivity could be caused by other factors or clinical pathology than DH, as self-reported on the screening questionnaire, which include:
Participant who has been/is on multiple prescription medications to treat severe acid reflux on a regular basis or has had surgery for acid reflux.
Participant with full or partial denture.
Participant who has undergone treatment for periodontal or gum disease within 6 months of screening or is currently undergoing treatment for periodontal or gum disease.
Participant who has been informed by a Dental Health Care Professional (DHCP) that they have active periodontitis.
Participants who have been informed by a DHCP that they have active caries.
Participant with any chronic and/or severe painful health condition which lead to regular use of pain relief medications (more than 3 days a week).
Participant with known or suspected intolerance or hypersensitivity to the study materials (or closely related compounds) or any of their stated ingredients.